CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights ...
Operator: Good morning. Welcome to the Sage Therapeutics’ Fourth Quarter and Full-Year 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback